Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)
Clinical trial NCT01852110 · TERMINATED
Trial details
- NCT number
- NCT01852110
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-22
- Primary completion
- 2016-04-11
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.